Tejara Capital LTD Heron Therapeutics, Inc. Transaction History

Tejara Capital LTD

$216 Billion
Q2 2025

A detailed history of Tejara Capital LTD transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 4,517,415 shares of HRTX stock, worth $5.92 Million. This represents 4.34% of its overall portfolio holdings.

Number of Shares

4,517,415

Previous 4,577,407 1.31%

Holding current value

$5.92 Million

Previous $10.1 Billion 7.14%

% of portfolio

4.34%

Previous 3.89%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$1.72 - $2.42 $103,186 - $145,180	-59,992 Reduced 1.31%	4,517,415 $9.35 Billion
Q1 2025 May 13, 2025	SELL	$1.47 - $2.55 $123,685 - $214,556	-84,140 Reduced 1.8%	4,577,407 $10.1 Billion
Q4 2024 Feb 10, 2025	SELL	$1.06 - $2.12 $682,925 - $1.37 Million	-644,269 Reduced 12.14%	4,661,547 $7.13 Billion
Q3 2024 Nov 13, 2024	BUY	$1.73 - $3.67 $1.93 Million - $4.1 Million	1,117,956 Added 26.7%	5,305,816 $10.6 Billion
Q2 2024 Aug 13, 2024	SELL	$2.32 - $3.86 $519,000 - $863,509	-223,707 Reduced 5.07%	4,187,860 $14.7 Billion
Q1 2024 May 14, 2024	SELL	$1.71 - $3.06 $1.48 Million - $2.64 Million	-863,669 Reduced 16.37%	4,411,567 $12.2 Billion
Q4 2023 Feb 12, 2024	BUY	$0.54 - $1.82 $1.71 Million - $5.76 Million	3,165,555 Added 150.05%	5,275,236 $8.97 Billion
Q3 2023 Nov 13, 2023	BUY	$0.97 - $1.8 $455,461 - $845,186	469,548 Added 28.63%	2,109,681 $2.17 Billion
Q2 2023 Aug 11, 2023	SELL	$1.11 - $2.88 $30,398 - $78,871	-27,386 Reduced 1.64%	1,640,133 $1.9 Billion
Q1 2023 May 12, 2023	BUY	$1.51 - $3.25 $1.77 Million - $3.82 Million	1,173,900 Added 237.81%	1,667,519 $2.52 Billion
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $1.11 Million - $2.31 Million	493,619 New	493,619 $1.23 Billion

Others Institutions Holding HRTX

# of Institutions

185

Shares Held

130M

Call Options Held

1.56M

Put Options Held

27.1K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $156M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.

Account

Tejara Capital LTD Heron Therapeutics, Inc. Transaction History